Hepregen's Series A Round

Hepregen raised a round of funding on February 05, 2009.

Hepregen, a spinout of MIT, is developing a platform to reduce the liver toxicity caused by approved drugs. The platform is based on technology developed by Sangeeta Bhatia, an associate professor in …

Articles about Hepregen's Series A Round: